4 completed, 1 unknown. 3 Phase 3, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow ketotifen fumarate ophthalmic solution: new trials by email Literature Review of ketotifen fumarate ophthalmic solution trials Research Report on ketotifen fumarate ophthalmic solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19 Ketotifen/Indomethacin, Placebo - COVID-19 Respiratory Infection | Phase 3 | Completed | Sen-Jam Pharmaceutical | 150 | 2022-05-03 | 2024-06-24 |
| A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and Vehicle EM-100, Zaditor®, Vehicle - Allergic Conjunctivitis | Phase 3 | Completed | Bausch & Lomb Incorporated | 65 | 2018-04-07 | 2023-06-08 |
| Ketotifen as a Treatment for Vascular Leakage During Dengue Fever Ketotifen, Placebo - Dengue Fever, Pleural Effusion | Phase 4 | Unknown | National University Hospital, Singapore | 110 | 2015-03-01 | 2016-02-04 |
| Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot Study Ketotifen, Placebo (Sugar Pill) - Fibromyalgia | Phase 3 | Completed | Indiana University | 51 | 2012-03-01 | 2016-11-17 |
| Safety and Comfort of AL-4943A Ophthalmic Solution Olopatadine hydrochloride ophthalmic solution, 0.7%, Olopatadine hydrochloride ophthalmic solution vehicle, Ketotifen fumarate ophthalmic solution, 0.025% - Allergic Conjunctivitis | Phase 1 | Completed | Alcon Research | 50 | 2011-04-01 | 2015-03-03 |
Conjunctivitis, Allergic (2) · Dengue (1) · Fibromyalgia (1) · Pleural Effusion (1) · Severe Dengue (1)
Alcon Research (1) · Bausch & Lomb Incorporated (1) · Indiana University (1) · National University Hospital, Singapore (1) · Sen-Jam Pharmaceutical (1)
United States (2) · Nepal (1) · Singapore (1)
Abhijit Narvekar, MS, MBBS (1) · Alexander T Limkakeng, MD (1) · Ashley L St John (1) · Dennis C. Ang, MD (1) · Paul A Tambyah (1)